================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 6, 2004
-------------------
MediCor, Ltd.
(Exact name of Registrant as Specified in its Charter)
Delaware 000-50442 14-1871462
(State or Other (Commission File Number) (IRS Employer
Jurisdiction of Identification No.)
Incorporation)
4560 South Decatur Boulevard, Suite 300, Las Vegas, NV 89103
(Address of Principal Executive Offices)
(702) 932-4560
(Registrant's Telephone Number, Including Area Code)
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
================================================================================
- --------------------------------------------------------------------------------
Item 5. Other Events
MediCor, Ltd. (the "Company") issued a press release on July 6, 2004. The press
release announced the Company had completed the acquisition of Laboratoires
Eurosilicone S.A. A copy of the press release is attached hereto as Exhibit 99.1
and incorporated herein by reference.
Item 7. Financial Statements and Exhibits
(c) Exhibits
Exhibit No. Description
99.1 Copy of press release issued by the Company on July 6, 2004
- --------------------------------------------------------------------------------
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
MEDICOR, LTD.
By:/s/ TR Maloney
--------------
Name: Theodore R. Maloney
Title: Chief Executive Officer